Global Covid-19 Treatment Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
- SKU ID : GIR-GIR2204290001 20952994
- |
- Publishing Date: 20-May-2022
- |
- Region: Global
- |
- No. of pages: 99
The Covid-19 Treatment Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our researcher latest study, due to COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Mild-to-Moderate COVID-19 accounting for % of the Covid-19 Treatment Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Covid-19 Treatment Medicine include Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), and Regeneron (Ronapreve), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Covid-19 Treatment Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injetion
Market segment by Application can be divided into
Mild-to-Moderate COVID-19
Severe Patient
The key market players for global Covid-19 Treatment Medicine market are listed below:
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Covid-19 Treatment Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Covid-19 Treatment Medicine, with price, sales, revenue and global market share of Covid-19 Treatment Medicine from 2019 to 2022.
Chapter 3, the Covid-19 Treatment Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Covid-19 Treatment Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Covid-19 Treatment Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment Medicine.
Chapter 13, 14, and 15, to describe Covid-19 Treatment Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our researcher latest study, due to COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Mild-to-Moderate COVID-19 accounting for % of the Covid-19 Treatment Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Covid-19 Treatment Medicine include Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), and Regeneron (Ronapreve), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Covid-19 Treatment Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injetion
Market segment by Application can be divided into
Mild-to-Moderate COVID-19
Severe Patient
The key market players for global Covid-19 Treatment Medicine market are listed below:
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Covid-19 Treatment Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Covid-19 Treatment Medicine, with price, sales, revenue and global market share of Covid-19 Treatment Medicine from 2019 to 2022.
Chapter 3, the Covid-19 Treatment Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Covid-19 Treatment Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Covid-19 Treatment Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment Medicine.
Chapter 13, 14, and 15, to describe Covid-19 Treatment Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
